Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Blood
  • 1.4.3 Semen
  • 1.4.4 Urine
• 1.5 Market by Application
  • 1.5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostics
  • 1.5.3 Drug Discovery
  • 1.5.4 Personalized Medicine
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Prostate Specific Antigen (PSA) Biomarker Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Prostate Specific Antigen (PSA) Biomarker Industry
    • 1.6.1.1 Prostate Specific Antigen (PSA) Biomarker Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Prostate Specific Antigen (PSA) Biomarker Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Prostate Specific Antigen (PSA) Biomarker Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Prostate Specific Antigen (PSA) Biomarker Market Perspective (2015-2026)
• 2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Regions
  • 2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prostate Specific Antigen (PSA) Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prostate Specific Antigen (PSA) Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Market Size
  • 3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
  • 3.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2019
• 3.3 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
• 3.4 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
• 3.5 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2021-2026)

5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
• 5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 6.2 Prostate Specific Antigen (PSA) Biomarker Key Players in North America (2019-2020)
• 6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 7.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 8.2 Prostate Specific Antigen (PSA) Biomarker Key Players in China (2019-2020)
• 8.3 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 8.4 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 9.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 10.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 11.2 Prostate Specific Antigen (PSA) Biomarker Key Players in India (2019-2020)
• 11.3 India Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 11.4 India Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
• 12.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview and Its Total Revenue
  • 13.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Siemens Healthcare
  • 13.2.1 Siemens Healthcare Company Details
  • 13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
  • 13.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.2.5 Siemens Healthcare Recent Development
• 13.3 DiaSorin
  • 13.3.1 DiaSorin Company Details
  • 13.3.2 DiaSorin Business Overview and Its Total Revenue
  • 13.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.3.5 DiaSorin Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview and Its Total Revenue
  • 13.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Tosoh Bioscience
  • 13.5.1 Tosoh Bioscience Company Details
  • 13.5.2 Tosoh Bioscience Business Overview and Its Total Revenue
  • 13.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.5.5 Tosoh Bioscience Recent Development
• 13.6 Fujirebio
  • 13.6.1 Fujirebio Company Details
  • 13.6.2 Fujirebio Business Overview and Its Total Revenue
  • 13.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.6.5 Fujirebio Recent Development
• 13.7 BodiTech
  • 13.7.1 BodiTech Company Details
  • 13.7.2 BodiTech Business Overview and Its Total Revenue
  • 13.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.7.5 BodiTech Recent Development
• 13.8 GE Healthcare
  • 13.8.1 GE Healthcare Company Details
  • 13.8.2 GE Healthcare Business Overview and Its Total Revenue
  • 13.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.8.5 GE Healthcare Recent Development
• 13.9 Endocare
  • 13.9.1 Endocare Company Details
  • 13.9.2 Endocare Business Overview and Its Total Revenue
  • 13.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.9.5 Endocare Recent Development
• 13.10 Quest Diagnostics
  • 13.10.1 Quest Diagnostics Company Details
  • 13.10.2 Quest Diagnostics Business Overview and Its Total Revenue
  • 13.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
  • 13.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 13.10.5 Quest Diagnostics Recent Development
• 13.11 Bio-Rad Laboratories
  • 10.11.1 Bio-Rad Laboratories Company Details
  • 10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 10.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
  • 10.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 10.11.5 Bio-Rad Laboratories Recent Development
• 13.12 QIAGEN
  • 10.12.1 QIAGEN Company Details
  • 10.12.2 QIAGEN Business Overview and Its Total Revenue
  • 10.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
  • 10.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 10.12.5 QIAGEN Recent Development
• 13.13 Myriad RBM
  • 10.13.1 Myriad RBM Company Details
  • 10.13.2 Myriad RBM Business Overview and Its Total Revenue
  • 10.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
  • 10.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
  • 10.13.5 Myriad RBM Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer